Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC Selects Location for New Global R&D Centre


Tuesday, 18 Jun 2013 03:08am EDT 

AstraZeneca PLC announced that its new United Kingdom-based global research and development centre and corporate headquarters will be located at the Cambridge Biomedical Campus on the southern outskirts of the city. By 2016, the new site will house a workforce of approximately 2,000. As announced on March 18, 2013, the investment in a GBP 330 million facility in Cambridge is part of the Company’s move to create strategic global R&D centres in the United Kingdom, United States and Sweden to improve pipeline productivity and to establish AstraZeneca as a global leader in biopharmaceutical innovation. 

Company Quote

3758.5
35.5 +0.95%
16 Apr 2014